Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance

UBC Medical Indonesia Tbk.Trade
Charlie Hospital Semarang Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.61M versus 635.5K). Which is the better fit depends on your goals.

LABSRSCH
Market Cap
691.25B1.11T
Volume
635.5K25.61M
Lot
6.36K256.07K
Turnover
110.15M10.76B
Average Price
173.33420.16
Value
110.15M10.76B
Indicative Equilibrium Price
174430
Indicative Equilibrium Volume
501.46K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
RSCH
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH